Periprosthetic Fracture Around Prosthetic Joint ImplantPRESPECTNCT04833634
Follow-Up of the Prevision® Hip Stem
An observational study of Periprosthetic Fracture Around Prosthetic Joint Implant and Aseptic Loosening of Prosthetic Joint, run by Aesculap AG at 1 site in Germany.
Trial summary
The main objective of this study is to represent the treatment reality at the study site and to draw conclusions from cases of failure or suboptimal outcome. Potential risk factors for revision surgery, suboptimal outcome or radiologic sign of loosening, bone non-union or stem subsidence will be evaluated. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Periprosthetic Fracture Around Prosthetic Joint Implant, Aseptic Loosening of Prosthetic Joint
- How many people
- 46 participants
- Where
- 1 siteGermany
- Study dates
- 14 May 2021to 13 Jun 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients were implanted 2-7 year before the start of the retrospective study activities.
Who may be able to join
- All patients implanted with a Prevision® hip stem at the study site between 2014 and 2019
- Written informed patient consent
Who cannot join
- Patients < 18 years at surgery
Trial locations and contacts
1 site in 1 country.
Germany1 site
Caritas-Krankenhaus Bad Mergentheim, Klinik für Orthopädie und Unfallchirurgie
Bad Mergentheim, 97980
About this study
Official title: Retrospective Follow-Up of the Prevision® Hip Stem in a Consecutive Case Series
The main objective of this study is to represent the treatment reality at the study site and to draw conclusions from cases of failure or suboptimal outcome. Potential risk factors for revision surgery, suboptimal outcome or radiologic sign of loosening, bone non-union or stem subsidence will be evaluated. Next to the functional outcome, stem subsidence will be used as an important indicator for a stable fixation of the revision stem.
- Conditions
- Periprosthetic Fracture Around Prosthetic Joint Implant, Aseptic Loosening of Prosthetic Joint
- Keywords
- arthroplasty, replacement, hip, implant failure, failed primary hip arthroplasty, severe bone defects, complex bone fractures, septic loosening, poor bone remodeling
What is being measured
The primary outcome is the main question the study is designed to answer.
Hip stem survival measured by Kaplan-Meier
The primary endpoint of the study is hip stem survival, which is a common indicator for implant performance, which can also be used for comparison with implant registry data.
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Secondary outcomes (8)
Functional Outcome: Oxford Hip Score
The Oxford Hip Score is a 12-item questionnaire that assesses hip function and pain. The score ranges between 12 and 60, with a lower score indicating less disability
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Patient satisfaction with their endoprosthetic revision treatment
The Patients are asked to grade their level of satisfaction with the outcome of the surgery at time of follow-up, with the grades: "very dissatisfied", "dissatisfied", "satisfied", "very satisfied".
The grades may be summarized as "satisfied" vs. "dissatisfied".
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): Bone healing
Union of the osteotomy
- Healing of the fracture and of the greater trochanter, if applicable
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): osseointegration
Distal and proximal radiographic bone ingrowth and Qualitative proximal remodeling
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): radiographic loosening
Signs of radiographic loosening in the distal fixation zone
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): stem subsidence
Stem subsidence from ap x-rays using landmarks of the femur (typically lesser trochanter) and of the prosthesis
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Leg length difference
Discrepancy of leg length is often considered to be a problem after total hip replacement and can adversely affect an otherwise excellent outcome and may be associated with patient dissatisfaction.
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Descriptive Analysis of (Serious) adverse events
(Serious) adverse events that are potentially related to the Total hip arthroplasty (THA) procedure or the THA implants will be recorded. These are events as reported by the patient, observed in the follow-up examinations or taken from the patient record
Measured: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2021
- Study start14 May 2021
- Primary completion13 Jun 2022
- Study completion13 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Periprosthetic Fracture Around Prosthetic Joint ImplantStudies of the same condition, open and under way.
- More trials run by Aesculap AGThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 46 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aesculap AG
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04833634
- Sponsor's protocol ID
- AAG-O-H-2008
- Acronym
- PRESPECT
- Status last verified
- Nov 2022
- First submitted
- 1 Apr 2021
- Last updated
- 18 Nov 2022
- Results posted
- No
- Data monitoring committee
- No
Publications
Herold D, Kuttner A, Dreyer L, Eingartner C. Mid-term results of a cementless hip stem in femoral revision: how much diaphyseal press-fit do we need? Arch Orthop Trauma Surg. 2024 Apr;144(4):1813-1820. doi: 10.1007/s00402-023-05191-4. Epub 2024 Jan 13.
PubMed 38217640
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Retrospective Follow-Up of the Prevision® Hip Stem in a Consecutive Case Series
- ClinicalTrials.gov ID
- NCT04833634
- Acronym / sponsor ID
- PRESPECT / AAG-O-H-2008
- Conditions
- Periprosthetic Fracture Around Prosthetic Joint Implant, Aseptic Loosening of Prosthetic Joint
- Keywords
- arthroplasty, replacement, hip, implant failure, failed primary hip arthroplasty, severe bone defects, complex bone fractures, septic loosening, poor bone remodeling
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 46 participants (actual)
- Lead sponsor
- Aesculap AGIndustry (pharma, biotech, devices)
- Study start
- 14 May 2021 (actual)
- Primary completion
- 13 Jun 2022 (actual)
- Study completion
- 13 Jun 2022 (actual)
- First posted
- 6 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective of this study is to represent the treatment reality at the study site and to draw conclusions from cases of failure or suboptimal outcome. Potential risk factors for revision surgery, suboptimal outcome or radiologic sign of loosening, bone non-union or stem subsidence will be evaluated. Next to the functional outcome, stem subsidence will be used as an important indicator for a stable fixation of the revision stem.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients were implanted 2-7 year before the start of the retrospective study activities.
Key inclusion criteria (2 listed)
- All patients implanted with a Prevision® hip stem at the study site between 2014 and 2019
- Written informed patient consent
Key exclusion criteria (1 listed)
- Patients < 18 years at surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Hip stem survival measured by Kaplan-Meier
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
The primary endpoint of the study is hip stem survival, which is a common indicator for implant performance, which can also be used for comparison with implant registry data.
8 secondary outcomes
Functional Outcome: Oxford Hip Score
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Patient satisfaction with their endoprosthetic revision treatment
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): Bone healing
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): osseointegration
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): radiographic loosening
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Radiological evaluation (standard x-rays): stem subsidence
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Leg length difference
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Descriptive Analysis of (Serious) adverse events
Time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2022.
- Derived from this study: PubMed 38217640Herold D, Kuttner A, Dreyer L, Eingartner C. Mid-term results of a cementless hip stem in femoral revision: how much diaphyseal press-fit do we need? Arch Orthop Trauma Surg. 2024 Apr;144(4):1813-1820. doi: 10.1007/s00402-023-05191-4. Epub 2024 Jan 13.
Related trials for Periprosthetic Fracture Around Prosthetic Joint Implant
Recruiting
Weight-Bearing CT Periprosthetic Distal Knee Fractures
Periprosthetic Fracture Around Prosthetic Joint Implant Knee
RecruitingObservational study
Investigating Periprosthetic Fracture Cultures in Arthroplasty
Periprosthetic Fracture Around Prosthetic Joint Implant
Recruiting
pDIFFIR: Geriatric Periprosthetic DIstal Femur: FIxation Versus Replacement
Distal Femur Fracture, Periprosthetic Fracture Around Prosthetic Joint Implant Knee
RecruitingObservational study
Periprosthetic Fracture Registry (PPFx)
Periprosthetic Fractures, Periprosthetic Fracture Around Prosthetic Joint Implant
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Periprosthetic Fracture Around Prosthetic Joint Implant and Aseptic Loosening of Prosthetic Joint, run by Aesculap AG at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hip stem survival measured by Kaplan-Meier (time frame: One scheduled Follow-Up visit per patient, 2-7 years after initial implantation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04833634, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2022.